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30 JULY 2009, THURSDAY
14:00-16:20 Meeting Room 201A&B Symposium co-organized by WPSC/GCACMID
Hot Spots in Asia Paciﬁc Region
Opening Remarks
Po-Ren Hsueh, Taipei
Yuxing Ni, Shanghai
Wing Hong Seto, Hong Kong
Antimicrobial Resistance in China
Yonghong Xiao, Beijing
MRSA Screening: Does It Work?
Bijie Hu, Shanghai
CLSI AST-2009 Update
Hui Wang, Beijing
Diseases Caused by Nontuberculous Mycobacteria (NTM)
Po-Ren Hsueh, Taipei
Closing Remarks
Po-Ren Hsueh, Taipei
Yuxing Ni, Shanghai
Wing Hong Seto, Hong Kong
31 JULY 2009, FRIDAY
08:00-08:30 Convention Hall 2A Opening Session
08:30-09:00 Convention Hall 2A State-of-the-Art 1
Antimicrobial Resistance and the Spread of Bacteria that are Resistant to
Cheap First-Line Drugs
Giuseppe Cornaglia, Verona
09:00-10:30 Convention Hall 2A Concurrent Session 1 – Immunology and Virology of Viral Hepatitis
Impact of Immunosuppression on Viral Hepatitis B and C
W. Ray Kim, Rochester
HBV Quasispecies in HBeAg Seroconversion
Seng-Gee Lim, Singapore
Immunological Effects of Type I Interferons in Hepatitis B Revisited: How Does
Interferon Work against HBV?
Heiner Wedemeyer, Hannover
Gender and HBV – Interaction between Human Sex Hormones and HBV
Transcription/Replication
Pei-Jer Chen, Taipei
Immune Evasion and the Liver
Xuefan Bai, Xi’an
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09:00-10:30 Convention Hall 2B Concurrent Session 2 – Gram-Positive Bacterial Infections and
Resistance
Clostridium difﬁcile Infections
Po-Ren Hsueh, Taipei
Streptococcus suis Infections in Humans
Constance Schultsz, Amsterdam
Streptococcus pyogenes Emm Type, Superantigens and Macrolid Resistance
Xuzhuang Shen, Beijing
VanA Type Vancomycin Resistant Enterococci in China
Bo Zheng, Beijing
09:00-10:30 Meeting Room 201A&B Concurrent Session 3 – Fungal Infections
Cryptococcosis in AIDS Patients: From Research to Practices in
Resource-Limited Settings
Somnuek Sungkanuparph, Bangkok
Harnessing Multidrug Resistance Gene Expression for Effective Antifungal
Strategies by a Natural Product Berberine
Lixin Zhang, Beijing
Combination Antifungals – Is There a Role?
Tan Ban Hock, Singapore
The Echinocandins and Formulary Decision
Mamie Hui, Hong Kong
10:30-11:30 Convention Hall 2A Industrial Supported Satellite Symposium – GlaxoSmithKline
11:30-11:45 BREAK
11:45-13:15 Convention Hall 2A Concurrent Session 4 – HCV Development and Strategies
Response-guided Therapy for Chronic Hepatitis C
Stefan Zeuzem, Frankfurt
Treatment of Different Genotypes in Chronic Hepatitis C
James Y.Y. Fung, Hong Kong
Mechanism of IFN-gamma in Anti-HCV Infection
Xuefan Bai, Xi’an
The Impact of Lipid Proﬁles on HCV RNA Levels in Patients with Genotypes 1
and 2
Chen-Hua Liu, Taipei
11:45-13:15 Convention Hall 2B Concurrent Session 5 – Gram-Negative Bacterial Infections and
Resistance
Complete Genome Sequence and Proteome of Laribacter hongkongensis,
a Novel Bacterium Associated with Gastroenteritis and Traveler’s Diarrhea
Patrick C.Y. Woo, Hong Kong
Resistance Trends and Treatment Options of Infections of Gram-Negatives
Minggui Wang, Shanghai
MDR, XDR, and PDR Gram-Negative Bacterial Infections: An Evolving Global
Public Health Problem
Matthew E. Falagas, Athens
TBC
Yehuda Carmeli, Tel Aviv
11:45-13:15 Meeting Room 201A&B Concurrent Session 6 – Parasitology and Tropical Infectious Diseases
Leishmaniasis as a Neglected Tropical Disease in the World, Eastern
Mediterranean Region and Iran
Hossein Nahrevanian, Tehran
Spatial and Temporal Distribution of Falciparum Malaria in China
Qiyong Liu, Beijing
Malaria Programmed Cell Death: Pathways and Perspectives
Kevin S.W. Tan, Singapore
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Identiﬁcation of a 16k Da Speciﬁc Protein from Cyst Fluid of Cysticercus and
its N-Terminal Amino Acid Sequencing
Siqi Lu, Beijing
13:15-13:45 Convention Hall 2B Industrial Supported Satellite Symposium – Roche
13:45-14:30 Convention Hall 2A Cholestasis Workshop
14:30-15:00 Convention Hall 2A State-of-the-Art 2
What Have We Learned on the Social and Psychological Fronts in SARS and
Human Swine Inﬂuenza
Joseph J.Y. Sung, Hong Kong
15:00-16:30 Convention Hall 2A Concurrent Session 7 – Management of Hepatitis C Patients
Management of Hepatitis C Patients and Prevention of HCC
Masao Omata, Tokyo
Managment of Hepatitis C Virus Infection in Patients with Chronic Renal
Failure and/or Thalassaemia
Wan-Cheng Chow, Singapore
TBC
W. Graham Cooksley, Brisbane
TBC
Lai Wei, Beijing
15:00-16:30 Convention Hall 2B Concurrent Session 8 – Gastrointestinal Infections
Norovirus Infection: An Emerging Enteric Infection
Joseph J.Y. Sung, Hong Kong
Blastocystis–Host Interactions: New Insights on Pathogenesis
Kevin S.W. Tan, Singapore
A Novel and Dominant Serotype Shigella ﬂexneri Fxb Emerging in China
Jianguo Xu, Beijing
Clinical Manifestation and Management of Enterovirus 71 Brain Stem
Encephalitis
Shih-Min Wang, Tainan
16:30-16:45 BREAK
16:45-17:45 Convention Hall 2B Free Paper Presentation 1 – Hepatitis C
16:45-17:45 Meeting Room 201A Free Paper Presentation 2 – Bacterial Infections/Antibiotics I
16:45-17:45 Meeting Room 201B Free Paper Presentation 3 – Parasitic/Gastro-intestinal Infections
16:45-17:45 Meeting Room 201C Free Paper Presentation 4 – Basic Science including Animal Models
17:45-18:00 BREAK
18:00-19:00 Convention Hall 2A Industrial Supported Satellite Symposium – Novartis
1 AUGUST 2009, SATURDAY
08:30-09:00 Convention Hall 2A State-of-the-Art 3
Global Strategy in the Usage of Antibiotics
Raul E. Isturiz, Caracas
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09:00-10:30 Convention Hall 2A Concurrent Session 9 – HBV: Treatment Options and Strategies
The Role of Currently Available Antiviral Drugs in Hepatitis B
Nancy W.Y. Leung, Hong Kong
The Role of Interferon Therapy in Hepatitis B
W. Graham Cooksley, Brisbane
Management of Drug Resistance of Hepatitis B: New Data from Chinese
Patients
Jinlin Hou, Guangzhou
09:00-10:30 Convention Hall 2B Concurrent Session 10 – Use and Abuse of Antibiotics
The Role of Infectious Disease Physician in the Rational Use of Antibiotics
Yonghong Xiao, Beijing
Antibiotic and Antifungal Resistance in Antibiotic “Free” Environment
Vladimir Krcmery, Bratislava
Antibiotic Resistance and the Role of Antibiotic Stewardship
Victor K.E. Lim, Kuala Lumpur
Problems with Empirical Antibiotics in Febrile Neutropenia
Tan Ban Hock, Singapore
09:00-10:30 Meeting Room 201A&B Concurrent Session 11 – HIV/AIDS
Molecular Epidemiological Study of HIV-1 CRF01_AE Transmission in Hong Kong
Wing Cheong Yam, Hong Kong
Clinical Retrospective Study of Haemophilia A Patients with AIDS after Long
Term HAART
Hongzhou Lu, Shanghai
Promoting HIV Screening and Voluntary Counselling and Testing as Important
Public Health Interventions
David Wilson, Sydney
Sustaining First-line Antiretroviral Regimens: The Third World Experience
Christopher K.C. Lee, Sungai Buloh
10:30-11:30 Convention Hall 2A Industrial Supported Satellite Symposium – Sino-American Shanghai
Squibb Pharmaceuticals Ltd.
11:30-11:45 BREAK
11:45-13:30 Convention Hall 2A Concurrent Session 12 – Management of Hepatitis B Patients
Diagnosis and Monitoring of Hepatitis B Patients
Qing Xie, Shanghai
Hepatitis B Vaccination in Children
Yen-Hsuan Ni, Taipei
Hepatitis B Virus Genetic Variability and its Clinical Signiﬁcance
Hong Tang, Chengdu
Hepatitis B and Transfusion Medicine: Unexpected Donor Screening Events
F. Blaine Hollinger, Houston
The Management of Chronic Hepatitis B Virus Infection in Immunosuppressed
Patients
Gui-Qiang Wang, Beijing
11:45-13:30 Convention Hall 2B Concurrent Session 13 – Tuberculosis
Treatment of MDR-TB and XDR-TB
Wing Wai Yew, Hong Kong
The Anti-TB Treatment for AIDS Patients Coinfection with TB
Hongzhou Lu, Shanghai
Molecular Diagnosis for Extensively Drug Resistant Tuberculosis (XDR-TB):
Current Practice and Challenges
Wing Cheong Yam, Hong Kong
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Antituberculous Therapy : The Impact of Pharmacokinetic-Pharmacodynamic
Parameters
Mamie Hui, Hong Kong
Identiﬁcation of Latent Tuberculosis Infection by QuantiFERON-TB GOLD,
ELISPOT, and Tuberculin Skin Test in End-Stage Renal Disease and Healthy
Controls
Ih-Jen Su, Tainan
11:45-13:30 Meeting Room 201A&B Concurrent Session 14 – AIDS/STD
Toward Timely HAART: Risks and Beneﬁts
Hongxin Zhao, Beijing
Interaction between Syphilis and HIV Infections
Joseph K.M. Kam, Hong Kong
Emerging of HIV-1 Drug Resistance and Solutions in Thailand
Somnuek Sungkanuparph, Bangkok
The Development of an AIDS Mucosal Vaccine
Zhiwei Chen, Hong Kong
13:30-14:00 Convention Hall 2B Industrial Supported Satellite Symposium – Schering-Plough
14:00-14:30 Poster Area 2/F Poster Session
14:30-15:00 Convention Hall 2A State-of-the-Art 4
Viral Hepatitis in China: The Research Findings and Clinical Application
Jidong Jia, Beijing
15:00-16:30 Convention Hall 2A Inﬂuenza Forum
Rapid and Sensitive Detection of Various Inﬂuenza Virus Subtypes Using SAT
Jingliang Ju, Shanghai
Successful Control of Inﬂuenza Using Stockpile of Tamiﬂu® during 2003/2004
SARS Period
Ih-Jen Su, Tainan
Clinical Effectiveness of Oseltamivir or Zanamivir for Inﬂuenza A/H1N1 Virus
with or without H274Y Mutation
Naoki Kawai, Tokyo
TBC
George F. Gao, Beijing
16:30-16:45 BREAK
16:45-17:45 Convention Hall 2B Free Paper Presentation 5 – Hepatitis B I
16:45-17:45 Meeting Room 201A Free Paper Presentation 6 – Bacterial Infections/Antibiotics II
16:45-17:45 Meeting Room 201B Free Paper Presentation 7 – HIV/AIDS/STD
16:45-17:45 Meeting Room 201C Free Paper Presentation 8 – Inﬂuenza
2 AUGUST 2009, SUNDAY
08:30-09:00 Convention Hall 2A State-of-the-Art 5
Refractory MRSA Infection in Hospital
Po-Ren Hsueh, Taipei
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09:00-10:30 Convention Hall 2A Concurrent Session 15 – Hepatitis and HCC
Can We Prevent Hepatocellular Carcinoma in Chronic Hepatitis B?
Henry L.Y. Chan, Hong Kong
Current Japanese Strategies for Preventing HCC Development
Yoshiyuki Ueno, Sendai
Prevention of HCC Related to Viral Hepatitis
Jun Cheng, Beijing
Discovery of PLK-1 Gene in Control of HCC
Seng-Gee Lim, Singapore
09:00-10:30 Convention Hall 2B Concurrent Session 16 – Global Monster – MRSA
A Work in Progress: MRSA and cMRSA in Latin America
Raul E. Isturiz, Caracas
Elucidating Geographical Spread of Methicillin-Resistant Staphylococcus
aureus (MRSA): From Molecular Typing, Multilocus Sequence Typing to
Microbial Genomics
Margaret Ip, Hong Kong
Molecular Characteristic of Community-Acquired, Methicillin-Resistant
Staphylococcus aureus
Xuzhuang Shen, Beijing
TBC
Atef M. Shibl, Riyadh
10:30-11:30 Convention Hall 2B Free Paper Presentation 9 – Hepatitis B II
10:30-11:30 Meeting Room 201A Free Paper Presentation 10 – Diagnosis & Laboratory Systems
Development
10:30-11:30 Meeting Room 201B Free Paper Presentation 11 – Tuberculosis/Respiratory Tract Infections
11:30-11:45 BREAK
11:45-13:15 Convention Hall 2A Concurrent Session 17 – End Stage Liver Diseases and Complications
Management of Hapititis Related Liver Cirrhosis (TBC)
Yuming Wang, Chongqing
Non-Invasive Assessment of Liver Fibrosis and Cirrhosis
Hong You, Beijing
Clinical Implications of Spontaneous Bacterial Peritonitis Due to
Antibiotic-Resistant Microorganism
Kyoung-Ho Song, Seongnam
11:45-13:15 Convention Hall 2B Concurrent Session 18 – Pneumonia – Yesterday, Today and Tomorrow
Pneumococcal Diseases in the 21st Century
Margaret Ip, Hong Kong
Pneumococcal Diseases Burden in Asia
Lulu C. Bravo, Manila
The Potential for Using Protein-Based Vaccines to Protect against
Pneumococcal Infection
Ju Cao, Chongqing
CAP with Respiratory Failure in the Asia-Paciﬁc Region: Leptospirosis and
Scrub Typhus
Yupin Suputtamongkol, Bangkok
